Minerva Neurosciences, Inc. (NERV)
2025-06-30 | ||||
|---|---|---|---|---|
| Research and development | 1,298,041 | |||
| General and administrative | 2,076,108 | |||
| Total expenses | 3,374,149 | |||
| Loss from operations | -3,374,149 | |||
| Investment income | 136,671 | |||
| Foreign exchange (losses) gains | -21,110 | |||
| Net loss | -3,258,588 | |||
| Earnings per share, basic, total | -0.43 | |||
| Earnings per share, diluted, total | -0.43 | |||
| Weighted average number of shares outstanding, basic | 7,568,981 | |||
| Weighted average shares of common stock outstanding - diluted | 7,568,981 | |||